How to appeal a Cigna bph procedures + medical therapy denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for bph procedures + medical therapy

Cited policy: Cigna coverage policy: Aquablation (AquaBeam) for BPH

Age 45-80 yr, LUTS attributed to BPH, IPSS >=12, prostate 30-150 cc, Qmax <=15 mL/s, inadequate response or intolerance to medical therapy. Performed at center with appropriate procedural experience.

How Cigna denies bph procedures + medical therapy — and how to counter it

Where Cigna pushes back: 1) Investigational / experimental despite FDA Dec 2017 PMA; 2) TURP / HoLEP first; 3) Insufficient operator-experience data; 4) Long-term durability unproven.

Counter-arguments that hold up: Aquablation FDA-approved Dec 2017 (PMA P170022). WATER J Urol 2018 (Gilling) — non-inferior to TURP at 6 mo with SUPERIOR safety + lower retrograde ejaculation. WATER-II J Urol 2019 (Bhojani) — for 80-150 cc prostates. WATER + WATER-II 5-yr final results J Urol 2023 confirm durability (PMID 37838991, 37115632). AUA BPH 2018 + 2023 amendment endorse including large prostates. Cat-I CPT code granted 2023.

What Cigna typically denies for bph procedures + medical therapy

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For bph procedures + medical therapy, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the bph procedures + medical therapy treatments most often flagged for prior auth, step therapy, or medical necessity review:

• UroLift
• Rezum
• Aquablation
• iTind
• Optilume BPH
• GreenLight PVP

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.